Biotech company Geron, long known for its pioneering research on stem cells, has announced that it will no longer conduct such research, reports New Scientist's Andy Coghlan. Geron's stem cell program was the largest in the world, and currently runs trials to treat various disorders and diseases with stem cell therapies, including one to treat people with spinal injuries, Coghlan says.
Get the full story
This story is free
for registered users
Registering provides access to this and other free content.
Register now.Already have an account?
Login Now.